Login / Signup

Secukinumab use in the treatment of Netherton's syndrome.

Christian GanEmma KingDavid Orchard
Published in: The Australasian journal of dermatology (2022)
Netherton syndrome is a rare, severe genetic disorder of cornification without specific treatment. We describe two cases who demonstrated marked cutaneous improvement with secukinumab and suggest a role for IL-17 therapy in treating this condition.
Keyphrases
  • stem cells
  • genome wide
  • rheumatoid arthritis
  • smoking cessation